AN OPEN-LABEL EXTENSION OF TWO PLACEBO-CONTROLLED STUDIES OF CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS: 18-MONTH UPDATE

被引:0
|
作者
Halford, J. [1 ]
Kalviainen, R. [2 ]
Ben-Menachem, E. [3 ]
Schmitt, J. [4 ]
Wiegand, F. [5 ]
Novak, G. [4 ]
机构
[1] Med Univ S Carolina, Charleston, SC USA
[2] Kupio Univ Hosp, Kupio Epilepsy Ctr, Kuopio, Finland
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci & Physiol, Gothenburg, Sweden
[4] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
[5] Johnson & Johnson Pharmaceut Serv LLC, Raritan, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:62 / 62
页数:1
相关论文
共 50 条
  • [1] AN OPEN-LABEL EXTENSION OF TWO CONTROLLED STUDIES OF CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS
    Halford, J.
    Kalviainen, R.
    Ben-Menachem, E.
    Schmitt, J.
    Wiegand, F.
    Novak, G.
    [J]. EPILEPSIA, 2009, 50 : 107 - 107
  • [2] Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials
    Sperling, Michael R.
    Greenspan, Andrew
    Cramer, Joyce A.
    Kwan, Patrick
    Kalviainen, Reetta
    Halford, Jonathan J.
    Schmitt, Jennifer
    Yuen, Eric
    Cook, Thomas
    Haas, Magali
    Novak, Gerald
    [J]. EPILEPSIA, 2010, 51 (03) : 333 - 343
  • [3] CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS IN TWO INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
    Sperling, Michael R.
    Greenspan, A.
    Cramer, Joyce
    Kwan, Patrick
    Kalviainen, R.
    Halford, Jonathan J.
    Schmitt, Jennifer L.
    Haas, M.
    Yuen, Eric
    Novak, Gerad
    [J]. EPILEPSIA, 2008, 49 : 106 - 107
  • [4] Six month efficacy and tolerability results of carisbamate as adjunctive treatment of partial onset seizures: experience from two open label extension studies
    Kalviainen, R.
    Ben-Menachem, E.
    Rosenfeld, W. E.
    Halford, J.
    Wiegand, F.
    Schmitt, J.
    Novak, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 474 - 474
  • [5] TOLERABILITY OF CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS IN THREE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Sperling, M. R.
    Faught, E.
    Schmitt, J.
    Wiegand, F.
    Novak, G.
    [J]. EPILEPSIA, 2009, 50 : 66 - 66
  • [6] CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS: RESULTS FROM AN ONGOING OPEN-LABEL EXTENSION OF A DOUBLE-BLIND RANDOMIZED DOSE RANGING STUDY
    Rosenfeld, W.
    Wiegand, F.
    Schmitt, J.
    Novak, G.
    [J]. EPILEPSIA, 2009, 50 : 52 - 52
  • [7] CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS: RESULTS AT 18 MONTHS FROM AN ONGOING OPEN-LABEL EXTENSION OF A DOUBLE-BLIND, RANDOMIZED, DOSE-RANGING STUDY
    Lippmann, S.
    Rosenfeld, W.
    Wiegand, F.
    Schmitt, J.
    Novak, G.
    [J]. EPILEPSIA, 2009, 50 : 65 - 65
  • [8] Carisbamate as Adjunctive Treatment for Partial Onset Seizures in Adults: Pharmacokinetic/Pharmacodynamic Modeling of Efficacy Based on Three Randomized, Placebo-Controlled Trials
    Faught, Edward
    Sperling, Michael R.
    De Ridder, Filip
    Schmitt, Jennifer
    Kimko, Hui C.
    Novak, Gerald
    [J]. NEUROLOGY, 2009, 72 (11) : A225 - A225
  • [9] A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures
    Halford, Jonathan J.
    Ben-Menachem, Elinor
    Kwan, Patrick
    Ness, Seth
    Schmitt, Jennifer
    Eerdekens, Marielle
    Novak, Gerald
    [J]. EPILEPSIA, 2011, 52 (04) : 816 - 825
  • [10] THE DOSE RESPONSE RELATIONSHIP OF CARISBAMATE AS AN ADJUNCTIVE TREATMENT FOR PARTIAL ONSET SEIZURES BASED ON PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF 3 RANDOMIZED, PLACEBO-CONTROLLED TRIALS
    Faught, E.
    Sperling, M.
    De Ridder, F.
    Schmitt, J.
    Kimko, H.
    Novak, G.
    [J]. EPILEPSIA, 2009, 50 : 51 - 51